Joep J. de Jong

Joep J. de Jong

Auto-generated profile, based on publicly available information

Joep J. de Jong

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2019 in Genome Medicine
Verified
Journal Article
Open access
PDF file
JJJoep J. de Jong
Joep J. de Jong
YLYang Liu
Yang Liu
ARA. Gordon Robertson
A. Gordon Robertson
RSRoland Seiler
Roland Seiler
CGClarice S. Groeneveld
Clarice S. Groeneveld
EGEwan A. Gibb
Ewan A. Gibb
Background: Muscle-invasive bladder cancer (MIBC) is a heterogeneous disease, and gene expression profiling has identified several molecular subtypes with distinct biological and clinicopathological characteristics. While MIBC subtyping has primarily been based on messenger RNA (mRNA), long non-coding RNAs (lncRNAs) may provide additional resolution.Methods: LncRNA expression was quantified from microarray data of a MIBC cohort treated with neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) (n = 223). Unsupervised consensus clustering of highly variant lncRNAs identified a four-cluster solution, which was characterized using a panel of MIBC biomarkers, regulon activity profiles, gene signatures, and survival analysis. The four-cluster solution was confirmed in The Cancer Genome Atlas (TCGA) cohort (n = 405). A single-sample genomic classifier (GC) was trained using ridge-penalized logistic regression and validated in two independent cohorts (n = 255 andn = 94).Results: NAC and TCGA cohorts both contained an lncRNA cluster (LC3) with favorable prognosis that was enriched with tumors of the luminal-papillary (LP) subtype. In both cohorts, patients with LP tumors in LC3 (LPL-C3) were younger and had organ-confined, node-negative disease. The LPL-C3 tumors had enhanced FGFR3, SHH, and wild-type p53 pathway activity. In the TCGA cohort, LPL-C3 tumors were enriched forFGFR3mutations and depleted forTP53andRB1mutations. A GC trained to identify these LPL-C3 patients showed robust performance in two validation cohorts.Conclusions: Using lncRNA expression profiles, we identified a biologically distinct subgroup of luminal-papillary MIBC with a favorable prognosis. These data suggest that lncRNAs provide additional information for higher-resolution subtyping, potentially improving precision patient management.

1 March 2022 in Journal of Urology
Verified
Journal Article
Open access
YLYair Lotan
Yair Lotan
JJJoep J. de Jong
Joep J. de Jong
VLVinnie Y. T. Liu
Vinnie Y. T. Liu
Tarek BismarTarek Bismar
Tarek Bismar
SBStephen A. Boorjian
Stephen A. Boorjian
JBJoost L. Boormans
Joost L. Boormans
Purpose:Neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) in patients with non-metastatic muscle-invasive bladder cancer (MIBC) confers an absolute survival benefit of 5-10%. There is...

1 February 2020 in Current Urology Reports
Verified
Journal Article
Closed access
PDF file
TJTuomas Jalanko
Tuomas Jalanko
JJJoep J. de Jong
Joep J. de Jong
EGEwan A. Gibb
Ewan A. Gibb
RSRoland Seiler
Roland Seiler
Peter Colin BlackPeter Colin Black
Peter Colin Black

1 December 2021 in European Urology Oncology
Verified
Journal Article
Closed access
Andrea NecchiAndrea Necchi
Andrea Necchi
DRDaniele Raggi
Daniele Raggi
PGPatrizia Giannatempo
Patrizia Giannatempo
LMLaura Marandino
Laura Marandino
EFElena Farè
Elena Farè
EGEwan A. Gibb
Ewan A. Gibb

21 April 2022 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JJJoep J. de Jong
Joep J. de Jong
BVBegoña P. Valderrama
Begoña P. Valderrama
JPJulia Perera
Julia Perera
NJNuria Juanpere
Nuria Juanpere
PCPaloma Cejas
Paloma Cejas
JBJoaquim Bellmunt
Joaquim Bellmunt

10 August 2024 in European Urology
Verified
Journal Article
Closed access
JJJoep J. de Jong
Joep J. de Jong
YLYair Lotan
Yair Lotan
JBJoost L. Boormans
Joost L. Boormans